ARCHETYPE Medication safety event (openEHR-EHR-EVALUATION.medication_safety_event.v1)

ARCHETYPE IDopenEHR-EHR-EVALUATION.medication_safety_event.v1
ConceptMedication safety event
DescriptionSummary of a patient safety event associated with medication for reporting purposes.
PurposeTo record a summary of a patient safety event associated with medication for reporting purposes.
References
Copyright© openEHR Foundation
AuthorsAuthor name: Dr Ian McNicoll
Organisation: Ocean Informatics, UK
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 25/06/2012
Other Details LanguageAuthor name: Dr Ian McNicoll
Organisation: Ocean Informatics, UK
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 25/06/2012
Other Details (Language Independent)
  • MD5-CAM-1.0.1: DE77C8A5A958AD6D3C30B89716CBF495
Keywords
LifecycleAuthorDraft
Language useden
Citeable Identifier1013.1.1866
data
Main event for case?Main event for case?: Is this the principal or main event recorded during the case?
Allowed values: {true}
Safety event typeSafety event type: The type of event reported.
Constraint:
New constraint
[*]

Constraint binding:
[SafetyEventType]
MEDRA classificationMEDRA classification: The category of event reported using MedDRA classification.
Constraint:
*New constraint(sl)
[**(sl)]
DateTime of event onsetDateTime of event onset: The date and/or time that the adverse event took place.
Description of eventDescription of event: A narrative description of the medication safety event.
Cause of eventCause of event: Details of the estimated cause of the event.
Estimated cause of eventEstimated cause of event: The reason suspected for this event occurring.
  • Verbal miscommunication [Verbal understanding]
  • Written miscomunication-Illegible handwritting [Written understanding]
  • Written miscomunication-Abbreviations [Illegible writing]
  • Written miscomunication-Non metric units of measurement [*]
  • Written miscomunication-Decimal point [*]
  • Misread or didnt read [*]
  • Misinterpretation of the order [*]
  • Sound-alike drug name [*]
  • Look-alike drug name [*]
  • Packaging-Inappropriate Packaging or Design [*]
  • Packing-Dosage form [*]
  • Packaging-Error due to similarity to another drug (colour, form, size) [*]
  • Packaging-Error due different strength [*]
  • Characteristics of the medicine [*]
  • Human factors-Lack of information/knowledge [*]
  • Work not accomplished [*]
  • Incomplete documentation [*]
  • Work overload, burn out syndrome [*]
  • Fatigue/Lack of sleep [*]
  • Confrontational or intimidating behaviour [*]
  • Control not carried out [*]
  • Inappropriate lighting [*]
  • Inappropriate temperature/humidity [*]
  • Frequent interuptions and distractions [*]
  • Lack of staff [*]
  • Other [*]
CommentComment: An additional comment on the estimated cause of the event.
Related triggerRelated trigger: Triggers thought to be related to this safety event recorded using IHCI classification.
Choice of:
  •  Coded Text
    • Transfusion of Blood or Use of Blood Products [**(en)]
    • Acute Dialysis [**(en)]
    • Positive Blood Culture [**(en)]
    • X-Ray or Doppler Studies for Emboli or Deep Vein Thrombosis [**(en)]
    • Decrease in Hemoglobin or Hematocrit of 25% or Greater [**(en)]
    • Patient Fall [**(en)]
    • Pressure Ulcers [**(en)]
    • Readmission within 30 Days [**(en)]
    • Restraint Use [**(en)]
    • Healthcare-Associated Infections [**(en)]
    • In-Hospital Stroke [**(en)]
    • Clostridium difficile Positive Stool [**(en)]
    • Partial Thromboplastin Time (PTT) Greater than 100 Seconds [**(en)]
    • International Normalized Ratio (INR) Greater than 6 [**(en)]
    • Glucose Less than 50 mg/dl [**(en)]
    • Rising BUN or Serum Creatinine Two Times (2x) over Baseline [**(en)]
    • Vitamin K Administration [**(en)]
    • Diphenhydramine (Benadryl) Administration [**(en)]
    • Romazicon (Flumazenil) Administration [**(en)]
    • Naloxone (Narcan) Administration [**(en)]
    • Anti-Emetic Administration [**(en)]
    • Over-Sedation/Hypotension [**(en)]
    • Abrupt Medication Stop [**(en)]
    • Intra- or Post-Operative Death [**(en)]
    • Mechanical Ventilation Greater than 24 Hours Post-Operatively [**(en)]
    • Intra-Operative Administration of Epinephrine, Norepinephrine, Naloxone, or Romazicon [**(en)]
    • Pneumonia Onset [**(en)]
    • Readmission to the Intensive Care Unit [**(en)]
    • Terbutaline Use [**(en)]
    • Platelet Count Less than 50,000 [**(en)]
    • Administration of Oxytocic Agents (such as oxytocin, methylergonovine, and 15-methyl-prostaglandin in the post-partum period) [**(en)]
    • Administration of General Anesthesia [**(en)]
    • Readmission to the ED within 48 Hours [**(en)]
    • Time in ED Greater than 6 Hours [**(en)]
    • Abnormal laboratory parameter [*]
    • Falsely abnormal laboratory parameter [*]
    • Unknown [**(en)]
    • No trigger [*]
  •  Text
Adverse effectAdverse effect: Details of one or more side effects.
Reaction detailsReaction details: Details of reaction
ReactionReaction: Description of the side-effect reported or observed using MEDRA or ATC codes.
Constraint:
*New constraint(sl)
[**(sl)]
CommentComment: An additional comment on the Reaction details.
DateTime of reaction onsetDateTime of reaction onset: The datetime at which the side effects began.
SeveritySeverity: The severity of the reaction.
  • Low [*]
  • Medium [*]
  • High [*]
Liklihood of causationLiklihood of causation: An estimate of how likely the side-effects noted are due to the safety event.
  • Low [*]
  • Medium [*]
  • High [*]
Intervention detailsIntervention details: Details of interventions.
Intervention additional detailsIntervention additional details: *
InterventionIntervention: The clinical intervention undertaken to resolve or ameliorate the adverse effect, uses PCNE terminology.
  • Prescriber informed [**(en)]
  • Nurse informed/instructed [**(en)]
  • Dispensing rejected [**(en)]
  • Drug recalled from the ward [**(en)]
  • Dietary regime changed [**(en)]
  • Food supplement discontinued [**(en)]
  • Food supplement initiated [**(en)]
  • Reconstitution solvent changed [**(en)]
  • Diluent changed [**(en)]
  • Medical device (or change) suggested [*]
  • Drug changed [**(en)]
  • Dose increased [**(en)]
  • Dose decreased [**(en)]
  • Dosage form changed [**(en)]
  • Administration interval changed [**(en)]
  • Drug discontinued [**(en)]
  • Drug initiated [**(en)]
  • Drug administration rate changed [**(en)]
  • Route of administration changed [**(en)]
  • Resuscitation required [**(en)]
  • Heamodialysis required [**(en)]
  • Transplantation required [**(en)]
  • Transfusion required [**(en)]
  • Operating procedure required [**(en)]
  • Additional laboratory test(s) required [**(en)]
  • Physiotherapy required [**(en)]
  • Psychotherapy required [**(en)]
  • Error corrected [*]
  • Monitoring required [*]
  • Patient informed [*]
  • Other [**(en)]
CommentComment: *
Intervention resultIntervention result: The result(s) of any interventions undertaken, recorded using MEDRA classification subset.
  • *Intervencija preprečila, da bi zaplet dosegel pacienta(en) [*(en)]
  • *Intervencija popolnoma odpravila posledice, ki jih je zaplet povzročil pacientu(en) [*(en)]
  • *Intervencija delno odpravila posledice, ki jih je zaplet povzročil pacientu(en) [*(en)]
  • *Intervencija ni odpravila posledic, ki jih je zaplet povzročil pacientu(en) [*(en)]
  • *Intervencija ni bila možna(en) [*(en)]
  • *Rezultat intervencije ni poznan(en) [*(en)]
  • *Zmanjšanje stroškov zdravljenja(en) [*(en)]
  • *Skrajšan čas hospitalizacije(en) [*(en)]
  • *Pacient je bil odpuščen(en) [*(en)]
  • *Izboljšana kvaliteta življenja(en) [*(en)]
Side effect recurrenceSide effect recurrence: This information is aplicable when at least one Intervention is Dose decreased or Drug discontinued
  • Yes [*]
  • No [*]
  • NA [*]
Actual patient outcome detailsActual patient outcome details: *
Actual patient outcomeActual patient outcome: The overall impact actually experienced by the patient.
  • [A] Circumstances or events that have the capacity to cause error [*]
  • [B] An error that did not reach the patient [*]
  • [C] An error that reached the patient but did not cause harm [*]
  • [D] An error that reache the patient and reqired monitoring or intervention to confirm that it resulted in no harm to the patient [*]
  • [E] Temporary harm to the patient and required intervention [*]
  • [F] Temporary harm to the patient and required initial or prolonged hospitalization [*]
  • [G] Permanent patient harm [*]
  • [H] Intervention required to sustain life [*]
  • [I] Patient death [*]
CommentComment: An additional comment on the Actual patient outcome comment.
Potential patient outcomePotential patient outcome: An assessment of potential impact on the patient if interventions had been unsuccesful. Uses the MERP index. other remediation had not occured.
  • [A] Circumstances or events that have the capacity to cause error [*]
  • [B] An error that did not reach the patient [*]
  • [C] An error that reached the patient but did not cause harm [*]
  • [D] An error that reache the patient and reqired monitoring or intervention to confirm that it resulted in no harm to the patient [*]
  • [E] Temporary harm to the patient and required intervention [*]
  • [F] Temporary harm to the patient and required initial or prolonged hospitalization [*]
  • [G] Permanent patient harm [*]
  • [H] Intervention required to sustain life [*]
  • [I] Patient death [*]
Patient outcome categoryPatient outcome category: The caetgory of impact on the patient's life.
  • Clinical [*]
  • Personal [*]
  • Economic [*]
Additional commentAdditional comment: Any additional comment or narrative.
Summary detailsSummary details: Details included only in Case Summary.
Admission diagnosis classificationAdmission diagnosis classification: Admission diagnosis using ICD classification.
Constraint:
*New constraint(sl)
[**(sl)]
Discharge diagnosis classificationDischarge diagnosis classification: Discharge diagnosis using ICD classification.
Constraint:
*New constraint(sl)
[**(sl)]
Link to main eventLink to main event: A link to the main case event.
Oncological case detailsOncological case details: Details required for oncological cases.
TNM classificationTNM classification: Malignant disease classification using TNM.
Constraint:
*New constraint(sl)
[**(sl)]
Effectiveness of therapyEffectiveness of therapy: *
  • Completely effective [The therapy has been fully effective.]
  • Partially effective [The therpay has been partially effective.]
  • Disease status unchanged [*]
  • Ineffective - disease progressing unchecked. [The therapy has been ineffective and the disease is progressing unchecked.]
Order of treatmentOrder of treatment: ???????
Reason for case closureReason for case closure: Reason for the case being closed.
  • Treatment complete [*]
  • Treatment aborted [*]
Reason treatment abortedReason treatment aborted: The reason why the treatment was aborted.
Medications involvedMedications involved: The medicine, vaccine or other therapetic good being ordered, administered to or used by the subject
Medications administeredMedications administered:

Medications administered is used to enter wrongly administered drug for Safety event type
at0254 Pacient dobil drugo zdravilo od predpisanega Wrong drug administered to a patient

Other contributorsAnže Droljc, Marand s.i.i, Slovenia
Translators
  • Slovenian: ?